Computational Analysis of siRNA Recognition by the Ago2 PAZ Domain and Identification of the Determinants of RNA-Induced Gene Silencing

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Kandeel, Mahmoud ^a,b   Kitade, Yukio ^a  

^a GIFU UNIVERSITY   (Japan)

^b Kafrelsheikh University   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ARGONAUTE 2 PROTEIN; SMALL INTERFERING RNA;

ARTICLE; BINDING AFFINITY; CHEMICAL STRUCTURE; COMPUTER ANALYSIS; CONTROLLED STUDY; CORRELATIONAL STUDY; ENERGY; FREE ENERGY; GENE SILENCING; HYDROGEN BOND; IN VIVO STUDY; INTERMOLECULAR ENERGY; LIGAND BINDING; MATHEMATICAL ANALYSIS; MOLECULAR DOCKING; MOLECULAR INTERACTION; MOLECULAR RECOGNITION; NONHUMAN; PAZ DOMAIN; PROTEIN DOMAIN; PROTEIN RNA BINDING; RECEPTOR BINDING; RNA INTERFERENCE; STATIC ELECTRICITY; VAN DER WAALS INTERACTION;

ANIMALS; ARGONAUTE PROTEINS; BINDING SITES; CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; DROSOPHILA PROTEINS; MOLECULAR DOCKING SIMULATION; NUCLEIC ACID CONFORMATION; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN INTERACTION DOMAINS AND MOTIFS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SOFTWARE;

EID: 84874153367     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057140     Document Type: Article

References (37)

1. Bouasker S, Simard MJ, (2009) Structural biology: Tracing Argonaute binding. Nature 461: 743-744.
2. Jaronczyk K, Carmichael JB, Hobman TC, (2005) Exploring the functions of RNA interference pathway proteins: some functions are more RISCy than others? The Biochemical journal 387: 561-571.
3. Jaskiewicz L, Filipowicz W, (2008) Role of Dicer in posttranscriptional RNA silencing. Current topics in microbiology and immunology 320: 77-97.
4. Koscianska E, Starega-Roslan J, Krzyzosiak WJ, (2011) The role of Dicer protein partners in the processing of microRNA precursors. PloS one 6: e28548.
5. Kitade Y, Akao Y, (2010) MicroRNAs and their therapeutic potential for human diseases: microRNAs, miR-143 and-145, function as anti-oncomirs and the application of chemically modified miR-143 as an anti-cancer drug. Journal of pharmacological sciences 114: 276-280.
6. Noguchi S, Mori T, Hoshino Y, Maruo K, Yamada N, et al. (2011) MicroRNA-143 functions as a tumor suppressor in human bladder cancer T24 cells. Cancer letters 307: 211-220.
7. Apparailly F, Jorgensen C (2012) siRNA-based therapeutic approaches for rheumatic diseases. Nature reviews Rheumatology.
8. Wang L, Shi J, Zhang H, Li H, Gao Y, et al. (2013) Synergistic anticancer effect of RNAi and photothermal therapy mediated by functionalized single-walled carbon nanotubes. Biomaterials 34: 262-274.
9. Wang J, Li LC, (2012) Small RNA and its application in andrology and urology. Translational andrology and urology 1: 33-43.
10. Somoza A, Terrazas M, Eritja R, (2010) Modified siRNAs for the study of the PAZ domain. Chemical communications 46: 4270-4272.
11. Sipa K, Sochacka E, Kazmierczak-Baranska J, Maszewska M, Janicka M, et al. (2007) Effect of base modifications on structure, thermodynamic stability, and gene silencing activity of short interfering RNA. RNA 13: 1301-1316.
12. Bramsen JB, Laursen MB, Nielsen AF, Hansen TB, Bus C, et al. (2009) A large-scale chemical modification screen identifies design rules to generate siRNAs with high activity, high stability and low toxicity. Nucleic acids research 37: 2867-2881.
13. Frank F, Sonenberg N, Nagar B, (2010) Structural basis for 5'-nucleotide base-specific recognition of guide RNA by human AGO2. Nature 465: 818-822.
14. Yan KS, Yan S, Farooq A, Han A, Zeng L, et al. (2003) Structure and conserved RNA binding of the PAZ domain. Nature 426: 468-474.
15. Lingel A, Simon B, Izaurralde E, Sattler M, (2004) Nucleic acid 3'-end recognition by the Argonaute2 PAZ domain. Nature structural & molecular biology 11: 576-577.
16. Boland A, Tritschler F, Heimstadt S, Izaurralde E, Weichenrieder O, (2010) Crystal structure and ligand binding of the MID domain of a eukaryotic Argonaute protein. EMBO reports 11: 522-527.
17. Boland A, Huntzinger E, Schmidt S, Izaurralde E, Weichenrieder O, (2011) Crystal structure of the MID-PIWI lobe of a eukaryotic Argonaute protein. Proceedings of the National Academy of Sciences of the United States of America 108: 10466-10471.
18. Yuan YR, Pei Y, Ma JB, Kuryavyi V, Zhadina M, et al. (2005) Crystal structure of A. aeolicus argonaute, a site-specific DNA-guided endoribonuclease, provides insights into RISC-mediated mRNA cleavage. Molecular cell 19: 405-419.
19. Tomari Y, Zamore PD, (2005) Perspective: machines for RNAi. Genes & Development 19: 517-529.
20. Wang Y, Juranek S, Li H, Sheng G, Wardle GS, et al. (2009) Nucleation, propagation and cleavage of target RNAs in Ago silencing complexes. Nature 461: 754-761.
21. Gu S, Jin L, Huang Y, Zhang F, Kay MA, (2012) Slicing-independent RISC activation requires the argonaute PAZ domain. Current biology: CB 22: 1536-1542.
22. Yoshikawa K, Ogata A, Matsuda C, Kohara M, Iba H, et al. (2011) Incorporation of biaryl units into the 5' and 3' ends of sense and antisense strands of siRNA duplexes improves strand selectivity and nuclease resistance. Bioconjugate chemistry 22: 42-49.
23. Gong W, Desaulniers JP, (2012) Gene-silencing properties of siRNAs that contain internal amide-bond linkages. Bioorganic & medicinal chemistry letters 22: 6934-6937.
24. Avino A, Ocampo SM, Perales JC, Eritja R, (2012) Synthesis and in vitro inhibition properties of siRNA conjugates carrying acridine and quindoline moieties. Chemistry & biodiversity 9: 557-566.
25. Zeng L, Zhang Q, Yan K, Zhou MM, (2011) Structural insights into piRNA recognition by the human PIWI-like 1 PAZ domain. Proteins 79: 2004-2009.
26. Taniho K, Nakashima R, Kandeel M, Kitamura Y, Kitade Y, (2012) Synthesis and biological properties of chemically modified siRNAs bearing 1-deoxy-D-ribofuranose in their 3'-overhang region. Bioorganic & medicinal chemistry letters 22: 2518-2521.
27. Kuboe S, Yoda M, Ogata A, Kitade Y, Tomari Y, et al. (2010) Diazirine-containing RNA photocrosslinking probes for the study of siRNA-protein interactions. Chemical communications 46: 7367-7369.
28. Ueno Y, Komatsuzaki S, Takasu K, Kitamura Y, Kitade Y (2009) Synthesis and properties of oligodeoxynucleotides containing biaryl units. Nucleic acids symposium series: 27-28.
29. Ueno Y, Watanabe Y, Shibata A, Yoshikawa K, Takano T, et al. (2009) Synthesis of nuclease-resistant siRNAs possessing universal overhangs. Bioorganic & medicinal chemistry 17: 1974-1981.
30. Ueno Y, Inoue T, Yoshida M, Yoshikawa K, Shibata A, et al. (2008) Synthesis of nuclease-resistant siRNAs possessing benzene-phosphate backbones in their 3'-overhang regions. Bioorganic & medicinal chemistry letters 18: 5194-5196.
31. Ueno Y, Kawada K, Shibata A, Yoshikawa K, Wataya Y, et al. (2008) Synthesis and silencing properties of siRNAs possessing lipophilic groups at their 3'-termini. Nucleic acids symposium series: 503-504.
32. Ueno Y, Kato T, Sato K, Ito Y, Yoshida M, et al. (2005) Synthesis and properties of nucleic acid analogues consisting of a benzene-phosphate backbone. The Journal of organic chemistry 70: 7925-7935.
33. Hsu KC, Chen YF, Lin SR, Yang JM, (2011) iGEMDOCK: a graphical environment of enhancing GEMDOCK using pharmacological interactions and post-screening analysis. BMC bioinformatics 12 Suppl 1: S33.
34. Li Y, Frenz CM, Li Z, Chen M, Wang Y, et al. (2011) Virtual and In vitro bioassay screening of phytochemical inhibitors from flavonoids and isoflavones against Xanthine oxidase and Cyclooxygenase-2 for gout treatment. Chemical biology & drug design.
35. Bikadi Z, Hazai E, (2009) Application of the PM6 semi-empirical method to modeling proteins enhances docking accuracy of AutoDock. Journal of cheminformatics 1: 15.
36. Rajasekaran R, Chen YP, (2012) Probing the structure of Leishmania major DHFR TS and structure based virtual screening of peptide library for the identification of anti-leishmanial leads. Journal of molecular modeling.
37. Song JJ, Liu J, Tolia NH, Schneiderman J, Smith SK, et al. (2003) The crystal structure of the Argonaute2 PAZ domain reveals an RNA binding motif in RNAi effector complexes. Nature structural biology 10: 1026-1032.